DENTSPLY SIRONA Inc.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
XRAY$9.70+1.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
- Financial Statements
The following consolidated financial statements of the Company are filed as part of this Form 10-K:
| Page | |
|---|---|
| Management’s Report on Internal Control Over Financial Reporting | 45 |
| Report of Independent Registered Public Accounting Firm | 46 |
| Consolidated Statements of Operations - Years ended December 31, 2025, 2024, and 2023 | 50 |
| Consolidated Statements of Comprehensive Loss - Years ended December 31, 2025, 2024, and 2023 | 51 |
| Consolidated Balance Sheets - December 31, 2025 and 2024 | 52 |
| Consolidated Statements of Changes in Equity - Years ended December 31, 2025, 2024, and 2023 | 53 |
| Consolidated Statements of Cash Flows - Years ended December 31, 2025, 2024, and 2023 | 54 |
| Note 1 - Significant Accounting Policies | 55 |
| Note 2 - Revenue Recognition | 63 |
| Note 3 - Stock Compensation | 64 |
| Note 4 - Loss Per Common Share | 66 |
| Note 5 - Comprehensive Loss | 67 |
| Note 6 - Segment and Geographic Information | 69 |
| Note 7 - Other (Income) Expense, Net | 75 |
| Note 8 - Inventories, Net | 75 |
| Note 9 - Property, Plant and Equipment, Net | 75 |
| Note 10 - Leases | 76 |
| Note 11 - Goodwill and Intangible Assets | 77 |
| Note 12 - Prepaid Expenses and Other Current Assets | 80 |
| Note 13 - Accrued Liabilities | 81 |
| Note 14 - Financing Arrangements | 81 |
| Note 15 - Equity | 83 |
| Note 16 - Income Taxes | 84 |
| Note 17 - Benefit Plans | 88 |
| Note 18 - Restructuring and Other Costs | 94 |
| Note 19 - Financial Instruments and Derivatives | 96 |
| Note 20 - Fair Value Measurement | 102 |
| Note 21 - Commitments and Contingencies | 103 |
| Note 22 - Subsequent Events | 108 |
- Financial Statement Schedule for the Years Ended December 31, 2025, 2024, and 2023.
The following financial statement schedule is filed as part of this Form 10-K and is covered by the Report of Independent Registered Public Accounting Firm
| Page | |
|---|---|
| Schedule II - Valuation and Qualifying Accounts for the Years Ended December 31, 2025, 2024, and 2023. | 109 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.